Startups
Schrödinger
Computational chemistry company combining physics-based molecular simulation and artificial intelligence to support drug discovery and materials design. Develops scientific software, collaborates with pharmaceutical and biotechnology partners and advances its own investigational therapeutic programs. Founded in 1990; publicly traded on Nasdaq as SDGR.
Founded 1990
Team
 Aleksey I. GerasyutoSenior Vice President, Discovery and Preclinical Development Sciences |
Arun OberoiBoard Member |
Barry HonigScientific Advisor |
Brian ShoichetScientific Advisor |
Bridget van KralingenBoard Member |
 Erica Del MonacoSenior Vice President, Software Sales |
Gary GinsbergBoard Member |
Gary SenderBoard Member |
 Jaren MaddenChief Corporate Affairs Officer and Head of Investor Relations |
Jeffrey A. ChodakewitzBoard Member |
 Karen AkinsanyaPresident, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships |
 Kristian JensenSenior Vice President, Biology and Structural Biology |
 Lingle WangSenior Vice President, Scientific Development |
 Mathew D. HallsSenior Vice President, Materials Science |
 Matt RepaskySenior Vice President, Life Sciences Products |
Michael LyntonChairman of the Board |
 Mike BeachySenior Vice President, Software Development |
Nancy A. ThornberryBoard Member |
 Nathalie LacosteSenior Vice President, Life Science Business |
 Patrick LortonExecutive Vice President, Chief Technology Officer and Chief Operating Officer, Software |
 Paul DavieExecutive Vice President, Chief Commercial Officer, Global Head of Software Sales and Marketing |
Pratyush TiwaryScientific Advisor |
 Ramy FaridPresident and CEO · Board Member |
Richard A. FriesnerCo-Founder and Board Member · Scientific Advisory Chairman |
 Richie JainChief Financial Officer |
 Robert AbelExecutive Vice President, Chief Scientific Officer, Platform |
Rosana KapellerBoard Member |
 Shane BraunerExecutive Vice President, Chief Information Officer |
William A. Goddard, IIIScientific Advisor |
 Yvonne TranChief Legal Officer and Chief People Officer |
Investments
| $346M2020-08-17 | Schrödinger | 0 participations |
| $232M2020-02-10 | Schrödinger | 0 participations |
| $110M2019-05-19 | Schrödinger | WuXi AppTec, The Invus Group, LLC, Laurion Capital Management, Deerfield, GV, Pavilion Capital |
| $65M2018-06-05 |  Nimbus Therapeutics | Atlas Venture, SR One, Bill Gates, Pfizer Ventures, Lightstone Ventures, Schrödinger |
| $22M2015-06-15 | Schrödinger | 0 participations |
| $20M2012-12-11 | Schrödinger | 0 participations |
| $10M2010-04-16 | Schrödinger | 0 participations |
| $8MUnknown date | Schrödinger | 0 participations |